Peripheral Nerve Catheters - an introductionAmit Pawa
In November 2019 Dr Pawa Delivered a Lecture to the South Thames Acute Pain Group, in Cobham, Just outside London, on Peripheral Nerve Catheters. This was meant to serve as an introduction to the subject and to outline some of the challenges and difficulties he had instituting these at his own trust.
Peripheral Nerve Catheters - an introductionAmit Pawa
In November 2019 Dr Pawa Delivered a Lecture to the South Thames Acute Pain Group, in Cobham, Just outside London, on Peripheral Nerve Catheters. This was meant to serve as an introduction to the subject and to outline some of the challenges and difficulties he had instituting these at his own trust.
A 4 part seminar on 3D cbct technology for seminar presentations. with added technical details and considerations with differences between a CT technology.
Also it features the technical parameters ,uses and how it is considered useful in each departments of medicine and dentistry.
1.Aim of Radiotherapy
The goal of radiotherapy is to deliver a prescribed dose of radiation to the Target while sparing surrounding Healthy tissues to the largest extent possible
2.Organ Motion
Intra-fraction motion
during the fraction
Heartbeat
Swallowing
Coughing
Eye movement
Inter-fraction motion
- in between the fractions
Tumour change
Weight gain/loss
Positioning deviation
Breathing
Bowel and rectal filling
Bladder filling
Muscle relaxation/tension
3. Respiratory motion affects:
Respiratory motion affects all tumour sites in the thorax, abdomen and Pelvis. Tumours in the Lung, Liver, Pancreas, Oesophagus, Breast, Kidneys, prostate
Tumour displacement varies depending on the site and organ Location
Lung tumours can move several cm in any direction during irradiation
It is most prevalent and prominent in Lung cancers
4. Problems associated with respiratory motion during RT
Image acquisition limitations
Treatment planning limitations
Radiation delivery limitations
5. Methods to Account for Respiratory Motion
1. Motion encompassing methods
2. Respiratory gating methods
3. Breath hold methods
4. Forced shallow breathing with abdominal compression
5. Real-time tumor tracking methods
Summary:
The management of respiratory motion in radiation oncology is an evolving field
IGRT provides a solution for combating organ motion in radiotherapy
Delivering higher dose to tumor and less dose to normal tissue.
Limited clinical studies, needs to be studied further
IGRT – the future of radiotherapy
A 4 part seminar on 3D cbct technology for seminar presentations. with added technical details and considerations with differences between a CT technology.
Also it features the technical parameters ,uses and how it is considered useful in each departments of medicine and dentistry.
1.Aim of Radiotherapy
The goal of radiotherapy is to deliver a prescribed dose of radiation to the Target while sparing surrounding Healthy tissues to the largest extent possible
2.Organ Motion
Intra-fraction motion
during the fraction
Heartbeat
Swallowing
Coughing
Eye movement
Inter-fraction motion
- in between the fractions
Tumour change
Weight gain/loss
Positioning deviation
Breathing
Bowel and rectal filling
Bladder filling
Muscle relaxation/tension
3. Respiratory motion affects:
Respiratory motion affects all tumour sites in the thorax, abdomen and Pelvis. Tumours in the Lung, Liver, Pancreas, Oesophagus, Breast, Kidneys, prostate
Tumour displacement varies depending on the site and organ Location
Lung tumours can move several cm in any direction during irradiation
It is most prevalent and prominent in Lung cancers
4. Problems associated with respiratory motion during RT
Image acquisition limitations
Treatment planning limitations
Radiation delivery limitations
5. Methods to Account for Respiratory Motion
1. Motion encompassing methods
2. Respiratory gating methods
3. Breath hold methods
4. Forced shallow breathing with abdominal compression
5. Real-time tumor tracking methods
Summary:
The management of respiratory motion in radiation oncology is an evolving field
IGRT provides a solution for combating organ motion in radiotherapy
Delivering higher dose to tumor and less dose to normal tissue.
Limited clinical studies, needs to be studied further
IGRT – the future of radiotherapy
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
5. Rapid advances in CT technology and image postprocessing
software
CT angiography: improved by increasing scan speed and
decreasing section thickness >> a powerful tool in neurovascular
imaging
CTA: - a rapidly evolving field in CT imaging
- a noninvasive tool for visualizing blood vessels
- acquisition of thin-slice continuous images of the vessels
- to create three-dimensional reformations
An Introduction to CTA
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
5
6. Greater volume covered per unit time
Faster scanning
Potential for CTA and Cardiac
Advantages of MDCT
HIGH TEMPORAL RESOULUTION
• Vascular work eg. CTA, CTV
• Phased scanning eg. Liver, Kidneys
• Functional work eg. CT Perfusion, Cardiac CT
AS WELL AS for
• Uncooperative patients
• Pediatrics
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
6
8. Attenuation of monochromatic x-ray
Inhomogenous object
Principle of Operation
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
8
9. Quantitative parameter in CT images
CT Number
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
9
10. WW: range of CT numbers
WL: center of the scale
Window Width & Window Level
Effect of window width and level on CT image display. (a) Level = 50; Width = 200. (b) Level =
50; Width = 400. The image in (a) is displayed with greater contrast and appears noisier than
that in (b).
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
10
11. Bone kernels: less high-frequency roll-off >> accentuate
higher frequencies at the expense of increased noise
Soft tissue kernels: more roll-off at higher frequencies
>> reduced noise but lower spatial resolution
Compromise Of Spatial And Contrast Resolution
Kernels
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
11
12. For Single Slice Scanners
For Multi Slice Scanners
Pitch Factor
table motion during one rotation
Slice Pitch = ---------------------------------------
slice thickness
table motion during one rotation
Beam Pitch = ---------------------------------------
Beam thickness
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
12
13. Lower Pitch >> more radiation dose
>> more details in images
Pitch Factor (cont.)
Beam Pitch > 1 Beam Pitch = 1
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
13
26. Intra/Extra Cranial CTA
Indication
• CVA & TIA
• One-sided weakness
• Inability to speak
• Vision defects or loss
• Severe dizziness and vertigo
• Head and neck trauma
• Suspected arterial insufficiency
• Suspected arterial dissection
• Aneurysms
• Blockages
• Blood clots
• Vascular malformations e.g. AVM
• Surgery planning r.g. for tumors
• Vessel rupture or tears
• Carotid-cavernous sinus fistulas
• Detect atherosclerotic plaques
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
26
27. Intra/Extra Cranial CTA
Indication (cont.)
Contraindication:
known hypersensitivity to iodinated contrast media
Known renal insufficiency
taking metformin
You have had an X-ray test using contrast material in at least past 4 days
Risks:
a small chance of cell/tissue damage from being exposed to radiation
Potential risks to the developing CNS for fetuses in pregnant patients
CM leakage from veins and spread under skin
ACR & ESUR Vs. FDA in breastfeeding mothers
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
27
34. Motion Artifact
Causes:
VOLUNTARY & INVOLUNTARY (cardiac/inspiration/pristaltic)
Correction:
Immobilization
Proper explanation of procedure
Short scan time
Motion reduction software (shimadzu –mac)
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
34
35. Streak Artifact
Causes:
Improper sampling of data
Partial volume averaging
Patient motion
Metal & beam hardening
Noise
Spiral scanning
Mechanical failure
Correction:
Software correction
Gantry angulation
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
35
36. Streak Artifact
Causes:
Improper sampling of data
Partial volume averaging
Patient motion
Metal & beam hardening
Noise
Spiral scanning
Mechanical failure
Correction:
Software correction
Gantry angulation
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
36
37. Ring Artifact
Causes:
Bad detector alignment
Correction:
Balancing algorithm utilization
Detector Calibration
Not using 3rd CT generation!
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
37
38. Beam Hardening Artifact
Causes:
Polyenergrtic x-ray spectrum
Change in average beam energy
Different length and materials on the way of beams
Correction:
Bow tie filter utilization
Special correction software
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
38
39. Partial Volume Artifact
Causes:
tissues of widely different absorption on the same CT voxel
producing a beam attenuation proportional to the average value
Correction:
Thin slices
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
39
41. Before having a CT Angiogram
tell your doctor if you:
Are or might be pregnant/ allergic to any medicines
Have a heart condition/ kidney problems/ Asthma/ Thyroid
problems/ multiple myeloma/ Diabetes
had a x-ray test using contrast material in the past 4 days
Become very nervous in small spaces
You may be asked not to eat or drink anything for several hours
before the test
Read test information form, Fill out the informed consent form
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
41
42. During the test
lie very still on a table that is attached to the CT scanner
contrast material will be put in a vein in your arm or hand.
The table will slide into the round opening of the scanner and move
slightly while the scanner takes pictures
You may hear a click or buzz as the table and scanner move
The technologist may ask you to hold your breath for a few seconds
at a time
You may be alone in the scanning room. But the technologist will
watch you through a window. You will be able to talk to him or her
through an intercom.
A CT angiogram usually takes no longer than 30 minutes
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
42
44. Which one is usually exposed to more radiation annually?
a) Nuclear plant workers
b) Flight crews
c) Miners
d) Nuclear medicine technologists
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
44
46. CTA injection protocol
To deliver an appropriate amount of iodine, at right injection rates
of highly concentrated contrast medium
Injection protocol varies according to the type of scanner and
velocity of acquisition
For this type of exam the best method to deliver the contrast
medium is bolus tracking
( a designated vessel of interest is monitored in real-time with low-
dose dynamic scanning and when the selected enhancement
threshold (from 80 to 120 HU) is reach, the scan begins )
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
46
47. CTA injection protocol (cont.)
un-enhanced and enhanced scans might be performed
A peripheral venous access with an 18 or 20 gauge needle is obtained Usually
the right antecubital vein is selected
The large amount of contrast material or a small amount of it followed by a
saline bolus chaser
The injection rate should be >4 mL/sec.
The acquisition should cover from the aortic arch in caudocranial direction
Recent advances:
40ml, 370mgI/ml of CM using 64-slice scanners
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
47
49. CTA image aquisition
Simultaneous enhancement of the arteries and veins on brain CTA
enhancing the venous structures may interfere with detailed evaluation of the
arterial structures and vice versa
The scan timing after the arrival of CM is one factor that affects the separation of
intracranial arteries and veins
16-row MDCT: inferior to the novel wide coverage detector CT >> low temporal
resolution
320-row MDCT: artery–vein separation on brain 3D-CTA. ( scanner equipped
with a detector coverage of 160mm per rotation >> 1.0 s scan time for the whole
brain)
Optimal scan timing >> sufficient enhancement for entire intracranial arteries or
veins >> minimal superimposition in each phase
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
49
52. Siemens Somatom Scope CT Scanner
Focus on clinical excellence
Ultra Fast Ceramics detector >> crystal clear images
Combined Applications to Reduce Exposure >> right dose to patients
Adaptive Signal Boost >> reduces image noise
Fully Assisting Scanner Technologies >> optimizes your process efficiency
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
52
53. Siemens Somatom Scope CT Scanner
Focus on cost efficiency
eCockpit – enables more cost-efficient operation with:
• eStart: extends the tube lifetime by pre-warming the tube before a scan
• eMode: reduces wear and tear on the scanner by instantly optimizing scan
parameters
• eSleep: saves energy by stopping gantry rotation during scan breaks
Small footprint – reduced space occupancy costs and low power requirements,
making installation quick and easy
Innovative service offerings – delivering sustainable investment protection and
predictable total cost of ownership (TCO)
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
53
57. MPR (Multiplanar Reformation)
Creates views in arbitrary planes without loss of information
Similar resolution to the original source images
No editing is required, but only 2D views can be generated
Applied for precise measurements
Be combined with another visualization technique
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
57
58. MIP (Maximum Intensity Projection)
Created by displaying only the highest attenuation value from the
data The depth information along the projection ray would lost
Bone elimination techniques are essential for processing vascular
MIP images
Thin-slab MIP images viewed interactively may be an alternative, as
the necessity for bone elimination is limited
Not suitable for the evaluation of stenosis in cases of dense
calcification or stents
Thin-slab MIP can provide an excellent “road map” of the vessel
course for further evaluation with MPR.
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
58
59. SSD (Shaded surface display)
Surface rendering: an algorithm that provides a good 3D impression
The surface is separated from other structure
Is done by thresholding: meeting the condition>> be represented
As with MIP, bone elimination techniques have to be applied to
extract the vascularstructures.
With binary data, densitometric information gets lost and makes
the method prone to undesirable artifacts
Volume rendering has supplanted shaded surface display in
virtually all CT angiography indications
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
59
60. VR (Volume Rendering)
creates a 3D impression and provides densitometric
Information
all acquired data may be used>> requires greater
processing power than other techniques
Visualization of CT angiography data with volume
rendering is based on transfer functions that map
measured intensities to colors and opacities
total transparency to total opacity are assigned along
artificial rays that pass through the data
Separation of different tissue types can be
performed by applying multiple trapezoids, which can
be color encoded.
does not correlate with the linear progression of
gray-scale values on conventional CT images Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
60
62. General principles of ALARA
Justification: The exam must be medically indicated
Optimization: The exam must be performed using doses that are
As Low As Reasonably Achievable
Limitation: While dose levels to occupationally exposed individuals
are limited to levels recommended by consensus organizations,
limits are not typical for medically-necessary exams or procedures
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
62
63. Why it’s so important?
To address concerns on the increased population exposure during
CT procedures
Various effective strategies for dose reduction in CT
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
63
64. Brief tutorial on Radiation Dose in CT
CTDI
• Primary
metric of
scanner
output
• Using acrylic
phantoms
• One axial
scan
DLP
• Overall
energy
delivered by a
given scan
protocol
• Scan length is
incorporated
E
• reflects the
stochastic risk
• Uses
conversion
factor
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
64
71. MRA at a glance
TOF
o Derives contrast between stationary tissues and flowing blood by manipulating
the magnitude of magnetization
o Moving spins have greater magnitude
o Uses longitudinal magnetization vector for imaging
PC
o Derives contrast between stationary tissues and flowing blood by manipulating
the Phase of magnetization
o Moving spins have nonzero phase
o Uses transverse magnetization vector for imaging
CE
Similar to CTA
Shortens T1 of blood vessels
Uses rapid bolus of Gd
Seyedeh Shokoofeh Mousavi Gezafroudi
Medical Physisc M.Sc
71
Editor's Notes
for each scan protocol and k = 0.0023 for head CT.